Europe PMC
open access
Acceptance of long-acting injectable HIV treatment and prevention options among people living with HIV and PrEP-service participants in Uganda
Abstract Background Long-acting injectable antiretroviral products provide alternatives to daily oral medication for both HIV treatment and prevention. Their successful introduction will depend not only on clinical efficacy but also on whether potential users consider the product
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- “It is a better option, but we need to see it work”: Perceived benefits, concerns and implementation requirements for long-acting injectable HIV treatment and prevention in Uganda#642706
- Mobile Technology to Extend Clinic-based Counseling for HIV+s in Uganda#1378536
- Ongoing Dynamic Choice to Address HIV Treatment Interruption in Malawi#813511
- Perceptions of Long-Acting HIV Pre-Exposure Prophylaxis and Preferences for Service Delivery Among Young Women in Tertiary Institutions in South Africa#786449
- Post‐Trial Access to Antiretrovirals: Who Owes What to Whom?#753848
Record · ID 1492196
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive